⌘K

Home/Filings/4/0001213900-24-026724

4//SEC Filing

Newman James W. Jr. 4

Accession 0001213900-24-026724

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 6:21 PM ET

Size

5.6 KB

Accession

0001213900-24-026724

Insider Transaction Report

Form 4

Period: 2024-03-25

ADIAL PHARMACEUTICALS, INC.ADIL

Newman James W. Jr.

Director

Transactions

Award
Stock Option (Right to Buy)
2024-03-25+12,000→ 12,000 total
Exercise: $1.35Exp: 2034-03-24→ Common Stock (12,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718364

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 6:21 PM ET
Size: 5.6 KB

View on SEC.gov